Find Clinical Trials | Cedars-Sinai

390 results found

Anus, Breast, Colon, Corpus Uteri, Esophagus, Eye and Orbit, Kidney ...

Bristol-Myers Squibb, CA2360001, Ph 1/2, Open-Label, Multi-center, NSCLC, BMS-986482, Solid Tumor

Primary : To assess the safety and tolerability of oral BMS-986482, as monotherapy or in combination with nivolumab SC, nivolumab + relatlimab FDC SC, or bevacizumab, to establish the MTD,MAD, and/or RP2D(s) in participants with advanced solid ...

Liver

SIRT with Tremelimumab and Durvalumab for Resectable Hepatocellular Carcinoma

This study focuses on people who have liver cancer (hepatocellular carcinoma-HCC) for which they will be undergoing surgical treatment. The purpose of the study is to evaluate the safety and tolerability of neoadjuvant treatment (treatment ...

Other

Registry of Deep Brain Stimulation with the VERCISE System

The purpose of this study is to collect real-world information on effects of a device called the Vercise Deep Brain Stimulation (DBS) system for treatment of patients with Parkinson's disease that is not well-controlled with ...

Lung

Checkpoint Blockade in Lung Cancer Patients in the Adjuvant Setting

The purpose of this study is to compare the usual treatment alone (immune-based therapy with medications like durvalumab) to the usual treatment plus an experimental medication, AZD6738 (ceralasertib), in people with lung cancer who have ...

Lung

Incorporating Pathologic Complete Response in Non-Small Cell Lung Cancer to Optimize Immunotherapy

The purpose of this study is to compare the usual approach of observation (closely watching a patient’s condition after surgery) to taking an immunotherapy drug, durvalumab (MEDI4736), in people with early-stage, non-small cell lung cancer ...